Drugs & Clinical Trials | By September 21, 2007 | By Sudip Ghosh, MDcloseSudip Ghosh, MD Name: Sudip Ghosh
Site: http://brainblogger.com
See All Articles by Author (42)
About: Dr. Ghosh is a surgeon at the University of Manchester, UK and a medical writer. | 0 Comments

Ethnic Medicine - Beyond Bidil

While Bidil’s patent for general use runs out in 2007, its FDA approval for “selective” use on people of African origin runs out in 2020. Despite being hailed by the US Food and Drug Administration in 2005 as a step towards the “promise of personalized medicine,” the question why two established anti-hypertensive drugs (hydralazine and isosorbide dinitrate have been around for many decades) in combination is promoted as a major medical breakthrough remains unanswered. Read more →